{"name":"MetaboMed Inc","slug":"metabomed-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxON2pRd1JNZ1JXQ0RTdm9ISk0yM1NPeGF5YjlfODVYZjc0a3lYWGx6cU1qSFJGSnlHeU1SZDZqeUh1bWNpRjdCZDBKTlUyLVVfazRyaW5odk5WZmk2bHIxWGFqb1FIb1lUVkkxWXlmamxOMjh6RUtOemQ5bjJKMFhtcDNkTHBlckd6V01QU2ZibVRMN1FWVlRVNHU2NzNlTEdObkpTd3A2NWNsaW1TWG1FVWxvc0dEX1FUR3V6SFJVVkpFN3Vkc0g4TDl1QnhtcHcwd2xfTTQ2YmhQUkl2cF9CVUF2YWZpSnNaLWpvTG1LRQ?oc=5","date":"2024-01-16","type":"pipeline","source":"PR Newswire","summary":"EpiVario Announces Acquisition of Acetyl CoA Synthetase 2 (ACSS2) Inhibitor Portfolio from Metabomed LTD - PR Newswire","headline":"EpiVario Announces Acquisition of Acetyl CoA Synthetase 2 (ACSS2) Inhibitor Portfolio from Metabomed LTD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPWV9NYUZKQndyRlVJcU9zSFgyM3dTaTl6SlVQMWMtcWtNVlo3S28wQXNlNkJkS3RpVHM3OHBHd29wR284NEpkdXY1eHZEcnNlWVkxMzFGU2hEZ1FSRVZST3B5RDY0R2g4ekhiX3E4bHZqS2I4bnl4cjY4TDBPeUlkaXJkNG5VQWgzb3lYLURmdG8?oc=5","date":"2020-09-09","type":"pipeline","source":"BioSpace","summary":"MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer - BioSpace","headline":"MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}